The findings are notable in part because therapies have already been approved to target C5aR1 in other diseases.

Researchers are also investigating the PD-1 immune checkpoint inhibitor as treatment before surgical and radiation treatment.

Initial surgery and subsequent chemotherapy led to successful treatment and a cancer-free status. Medical protocols can be complex, and patients should question and understand their treatment options.

Kathy Hochul is reminding everyone to get checked for skin cancer after she had a procedure to remove basal cell carcinoma from her nose ... like melanoma or squamous cell carcinoma, but it ...

Researchers have identified C5aR1 as a novel biomarker for metastasis risk and poor prognosis in patients with cutaneous ...

A new study by investigators from Mass General Brigham uncovers how a novel immunotherapy prevents squamous cell carcinoma, with benefits lasting five years after treatment. This therapy is the ...